Evaluation of Hematopoietic Stem Cell Expansion in the Presence of Garcinol

Overview

Journal Avicenna J Phytomed

Publisher Mashhad University of Medical Sciences

Date 2018 Nov 1

PMID 30377593

Citations 1

Authors

Azam Habibi

Masoud Soleimani

Amir Atashi

Mahshid AkhavanRahnama

Azadeh Anbarlou

Mansoureh Ajami

Monireh Ajami

Affiliations

Soon will be listed here.

Abstract

Objective: The application of human cord blood (hCB) is limited to children by using relatively small volume of cord blood that does not contain enough hematopoietic stem cells (HSCs). So, efforts for applying cord blood stem cells in transplantation have led to establishment of some approaches for ex vivo expansion of HSCs such as garcinol.

Materials And Methods: CD133+ HSCs were separated by a magnetic-activated cell sorting (MACS) system. Isolated cells were cultured with different doses of garcinol, SCF, TPO and FLT-3L. The optimal dose of garcinol for expansion of HSCs was determined by direct counting. Flow cytometry was used to evaluate the expression of CD133 marker to check the ability of garcinol in maintenance of HSCs. Colony forming cell (CFC) assay was performed to evaluate clonogenic capability of treated cells. The level of expression of gene was evaluated by RT-PCR. Data were analyzed using Student's t test.

Results: Our results showed that CD133 HSCs in the presence of garcinol (5-10 µM) had high expansion activity and cell counting showed that the number of cells in treated group was higher than control group (1.9 -fold) and CFC assay showed that the number of colonies following treatment with garcinol had 1.3-fold increase. Treatment of HSCs with garcinol resulted in 9.6-fold increase in terms of expression in comparison to control group.

Conclusion: The present study showed that garcinol can improve expansion of HSCs and enhance their potential for homing to bone marrow.

Citing Articles

Chromatin-modifying drugs and metabolites in cell fate control.

Yao Z, Chen Y, Cao W, Shyh-Chang N Cell Prolif. 2020; 53(11):e12898.

PMID: 32979011 PMC: 7653270. DOI: 10.1111/cpr.12898.

References

Boitano A, Wang J, Romeo R, Bouchez L, Parker A, Sutton S . Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science. 2010; 329(5997):1345-8. PMC: 3033342. DOI: 10.1126/science.1191536. View

Nishino T, Miyaji K, Ishiwata N, Arai K, Yui M, Asai Y . Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL. Exp Hematol. 2009; 37(11):1364-1377.e4. DOI: 10.1016/j.exphem.2009.09.001. View

Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin P, Driscoll T . Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003; 101(12):5061-7. DOI: 10.1182/blood-2001-12-0290. View

Anbarlou A, Atashi A, Soleimani M, AkhavanRahnama M, Bohloli M, Mossahebi-Mohammadi M . Differential characteristics of CD133(+) and CD133 (-) Jurkat cells. In Vitro Cell Dev Biol Anim. 2015; 51(6):556-61. DOI: 10.1007/s11626-015-9869-z. View

Nishino T, Wang C, Mochizuki-Kashio M, Osawa M, Nakauchi H, Iwama A . Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase. PLoS One. 2011; 6(9):e24298. PMC: 3171405. DOI: 10.1371/journal.pone.0024298. View

TeKippe M, Harrison D, Chen J . Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp Hematol. 2003; 31(6):521-7. DOI: 10.1016/s0301-472x(03)00072-9. View

Ko K, Holmes T, Palladinetti P, Song E, Nordon R, OBrien T . GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression. Stem Cells. 2010; 29(1):108-18. DOI: 10.1002/stem.551. View

Mayani H, Lansdorp P . Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells. 1998; 16(3):153-65. DOI: 10.1002/stem.160153. View

Ding S, Schultz P . A role for chemistry in stem cell biology. Nat Biotechnol. 2004; 22(7):833-40. DOI: 10.1038/nbt987. View

10.

Traycoff C, Abboud M, Laver J, Clapp D, Srour E . Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol. 1994; 22(13):1264-72. View

11.

Mantelingu K, Reddy B, Swaminathan V, Kishore A, Siddappa N, Pavan Kumar G . Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol. 2007; 14(6):645-57. DOI: 10.1016/j.chembiol.2007.04.011. View

12.

de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson B . Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant. 2008; 41(9):771-8. PMC: 4086223. DOI: 10.1038/sj.bmt.1705979. View

13.

Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J . Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997; 89(8):2644-53. View

14.

Kondo M, Wagers A, Manz M, Prohaska S, Scherer D, Beilhack G . Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003; 21:759-806. DOI: 10.1146/annurev.immunol.21.120601.141007. View

15.

Cohen Y, Nagler A . Umbilical cord blood transplantation--how, when and for whom?. Blood Rev. 2004; 18(3):167-79. DOI: 10.1016/S0268-960X(03)00064-X. View

16.

Konuma T, Oguro H, Iwama A . Role of the polycomb group proteins in hematopoietic stem cells. Dev Growth Differ. 2010; 52(6):505-16. DOI: 10.1111/j.1440-169X.2010.01191.x. View

17.

Kelly S, Sola C, de Lima M, Shpall E . Ex vivo expansion of cord blood. Bone Marrow Transplant. 2009; 44(10):673-81. PMC: 4157906. DOI: 10.1038/bmt.2009.284. View

18.

Frassoni F, Varaldo R, Gualandi F, Bacigalupo A, Sambuceti G, Sacchi N . The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases. Best Pract Res Clin Haematol. 2010; 23(2):237-44. DOI: 10.1016/j.beha.2010.06.003. View

19.

Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H . Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity. 2004; 21(6):843-51. DOI: 10.1016/j.immuni.2004.11.004. View

20.

Sideri A, Neokleous N, Brunet De La Grange P, Guerton B, Le Bousse Kerdilles M, Uzan G . An overview of the progress on double umbilical cord blood transplantation. Haematologica. 2011; 96(8):1213-20. PMC: 3148916. DOI: 10.3324/haematol.2010.038836. View